Levosimendan, The levosimendan placebo drug product is an immediate-release dosage form for oral administration.
TNX-103-07
Phase 3 small_molecule active
Quick answer
Levosimendan, The levosimendan placebo drug product is an immediate-release dosage form for oral administration. for Pulmonary Hypertension (PH) with Heart Failure with preserved left ventricular ejection fraction (PH-HFpEF) is a Phase 3 program (small_molecule) at TENAX THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TENAX THERAPEUTICS, INC.
- Indication
- Pulmonary Hypertension (PH) with Heart Failure with preserved left ventricular ejection fraction (PH-HFpEF)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active